Adolescent exposure to cannabis as a risk factor for psychiatric disorders

Journal of Psychopharmacology

Volumn 26, Issue 1, 2012, Pages 177-188

  Rubino, Tiziana ^a   Zamberletti, Erica ^a   Parolaro, Daniela ^a,b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Zardi Gori Foundation   (Italy)

Author keywords

Adolescence; cannabinoids; cannabis; cognition; emotionality; endocannabinoid system; gateway; psychiatric disorders; psychosis

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABINOID RECEPTOR; CANNABIS; DOPAMINE TRANSPORTER; ENDOCANNABINOID; PHENCYCLIDINE;

ANXIETY; BINDING AFFINITY; BRAIN MATURATION; CATALYSIS; COGNITION; DEPRESSION; EMOTIONALITY; ENVIRONMENTAL EXPOSURE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; HUMAN; IMMUNOREACTIVITY; LEARNING; MEMORY; MENTAL DISEASE; MOLECULAR DYNAMICS; MOOD DISORDER; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; PSYCHOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRANQUILIZING ACTIVITY; UPREGULATION;

ADOLESCENT; ANIMALS; BRAIN; CANNABIS; HUMANS; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; RISK FACTORS;

EID: 84856431319     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111405362     Document Type: Review

References (138)

1. Andreano JM, Cahill L. Sex influences on the neurobiology of learning and memory. Learn Mem. 2009 ; 16: 248-266
2. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002 ; 325: 1212-1213 (Pubitemid 35398785)
3. Aso E, Renoir T, Mengod G, Ledent C, Hamon M, Maldonado R, et al. Lack of CB1 receptor activity impairs serotonergic negative feedback. J Neurochem. 2009 ; 109: 935-944
4. Bambico FR, Nguyen NT, Katz N, Gobbi G. Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiol Dis. 2010 ; 37: 641-655
5. Barkus E, Murray RM. Substance use in adolescence and psychosis: clarifying the relationship. Annu Rev Clin Psychol. 2010 ; 6: 365-389
6. Bava S, Jacobus J, Mahmood O, Yang TT, Tapert SF. Neurocognitive correlates of white matter quality in adolescent substance users. Brain Cogn. 2009 ; 72: 347-354
7. Berton O, Ramos A, Chaouloff F, Mormde P. Behavioral reactivity to social and nonsocial stimulations: a multivariate analysis of six inbred rat strains. Behav Genet. 1997 ; 27: 155-166 (Pubitemid 27203931)
8. Biscaia M, Marín S, Fernández B, Marco EM, Rubio M, Guaza C, et al. Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood. Psychopharmacology (Berl). 2003 ; 170: 301-308 (Pubitemid 37491610)
9. Biscaia M, Fernández B, Higuera-Matas A, Miguéns M, Viveros MP, García-Lecumberri C, et al. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system. Neuropharmacology. 2008 ; 54: 863-873
10. Bossong MG, Niesink RJM. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol. 2010 ; 92: 370-385
11. Boucher AA, Arnold JC, Duffy L, Schofield PR, Micheau J, Karl T. Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta 9-tetrahydrocannabinol. Psychopharmacology (Berl). 2007 ; 192: 325-336 (Pubitemid 46705399)
12. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001 ; 156: 234-258 (Pubitemid 32705488)
13. Brusco A, Tagliaferro PA, Saez T, Onaivi ES. Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann NY Acad Sci. 2008 ; 1139: 450-457
14. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, et al. Moderation of the effect of adolescent onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry. 2005 ; 57: 1117-1127 (Pubitemid 40615773)
15. Cha YM, White AM, Kuhn CM, Wilson WA, Swartzwelder HS. Differential effects of delta 9-THC on learning in adolescent and adult rats. Pharmacol Biochem Behav. 2006 ; 83: 448-455 (Pubitemid 43736959)
16. Cha YM, Jones KH, Kuhn CM, Wilson WA, Swartzwelder HS. Sex differences in the effects of delta 9-tetrahydrocannabinol on spatial learning in adolescent and adult rats. Behav Pharmacol. 2007 ; 18: 563-569 (Pubitemid 47356382)
17. Cleveland HH, Wiebe RP. Understanding the association between adolescent marijuana use and later serious drug use: gateway effect or developmental trajectory?. Dev Psychopathol. 2008 ; 20: 615-632 (Pubitemid 351584027)
18. Cohen-Cory S. The developing synapse: construction and modulation of synaptic structures and circuits. Science. 2002 ; 298: 770-776 (Pubitemid 35231520)
19. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003 ; 98: 1493-1504 (Pubitemid 37373847)
20. Degenhardt L, Dierker L, Chiu WT, Medina-Mora ME, Neumark Y, Sampson N, et al. Evaluating the drug use 'gateway' theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend. 2010 ; 108: 84-97
21. de Graaf R, Radovanovic M, van Laar M, Fairman B, Degenhardt L, Aguilar-Gaxiola S, et al. Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the population-based World Health Organization World Mental Health Survey Initiative. Am J Epidemiol. 2010 ; 172: 149-159
22. Dekker N, Linszen DH, De Haan L. Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders. Psychopathology. 2009 ; 42: 350-360
23. De Petrocellis L, Di Marzo V. An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endocrinol Metab. 2009 ; 23: 1-15
24. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992 ; 258: 1946-1949 (Pubitemid 23026736)
25. Di Forti M, Morrison PD, Butt A, Murray RM. Cannabis use and psychiatric and cognitive disorders: the chicken or the egg?. Curr Opin Psychiatry. 2007 ; 20: 228-234 (Pubitemid 46588294)
26. Di Marzo V, Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol. 2007 ; 18: 129-140 (Pubitemid 46412082)
27. Dominguez MD, Saka MC, Lieb R, Wittchen HU, van Os J. Early expression of negative/disorganized symptoms predicting psychotic experiences and subsequent clinical psychosis: a 10-year study. Am J Psychiatry. 2010 ; 167: 1075-1082
28. Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, et al. Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry. 2010 ; 55: 165-171
29. D'Souza DC, Sewell RA, Ranganathan M. Cannabis and psychosis/ schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci. 2009 ; 259: 413-431
30. Eggan SM, Mizoguchi Y, Stoyak SR, Lewis DA. Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cereb Cortex. 2010 ; 20: 1164-1174
31. Ehrenreich H, Rinn T, Kunert HJ, Moeller MR, Poser W, Schilling L, et al. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl). 1999 ; 142: 295-301 (Pubitemid 29200157)
32. Eldreth DA, Matochik JA, Cadet JL, Bolla KI. Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage. 2004 ; 23: 914-920 (Pubitemid 39446525)
33. Ellgren M, Hurd YL, Franck J. Amphetamine effects on dopamine levels and behavior following cannabinoid exposure during adolescence. Eur J Pharmacol. 2004 ; 497: 205-213 (Pubitemid 39092574)
34. Ellgren M, Spano SM, Hurd YL. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology. 2007 ; 32: 607-615
35. Ellgren M, Artmann A, Tkalych O, Gupta A, Hansen HS, Hansen SH, et al. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol. 2008 ; 18: 826-834
36. Ferdinand RF, van der Ende J, Bongers I, Selten JP, Huizink A, Verhulst FC. Cannabis-psychosis pathway independent of other types of psychopathology. Schizophr Res. 2005 ; 79: 289-295 (Pubitemid 41457269)
37. Fergusson DM, Horwood LJ, Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction. 2002 ; 97: 1123-1135
38. Fergusson DM, Horwood LJ, Lynskey MT, Madden PA. Early reactions to cannabis predict later dependence. Arch Gen Psychiatry. 2003 ; 60: 1033-1039 (Pubitemid 37222087)
39. Fergusson DM, Poulton R, Smith PF, Boden JM. Cannabis and psychosis. BMJ. 2006a ; 332: 172-175 (Pubitemid 43139414)
40. Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006b ; 101: 556-566
41. File SE, Hyde JR. Can social interaction be used to measure anxiety?. Br J Pharmacol. 1978 ; 62: 19-24 (Pubitemid 8251893)
42. Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev. 2003 ; 83: 1017-1066 (Pubitemid 36828930)
43. Fried PA, Watkinson B, Gray R. Neurocognitive consequences of marihuana-a comparison with predrug performance. Neurotoxicol Teratol. 2005 ; 27: 231-239 (Pubitemid 40279133)
44. Galve-Roperh I, Palazuelos J, Aguado T, Guzmán M. The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders. Eur Arch Psychiatry Clin Neurosci. 2009 ; 259: 371-382
45. Geyer MA. Developing translational animal models for symptoms of schizophrenia or bipolar mania. Neurotox Res. 2008 ; 14: 71-78
46. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 1999 ; 2: 861-863 (Pubitemid 30602596)
47. Glass M, Felder CC. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci. 1997 ; 17: 5327-5333
48. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006 ; 1071: 10-23 (Pubitemid 43255471)
49. Hall W, Degenhardt L. Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry. 2007 ; 20: 393-397 (Pubitemid 46889667)
50. Hall WD, Lynskey M. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev. 2005 ; 24: 39-48 (Pubitemid 41052845)
51. Hanson KL, Winward JL, Schweinsburg AD, Medina KL, Brown SA, Tapert SF. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence. Addict Behav. 2010 ; 35: 970-976
52. Harvey MA, Sellman JD, Porter RJ, Frampton CM. The relationship between non-acute adolescent cannabis use and cognition. Drug Alcohol Rev. 2007 ; 26: 309-319
53. Hayatbakhsh MR, Najman JM, Jamrozik K, Mamun AA, Alati R, Bor W. Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry. 2007 ; 46: 408-417
54. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull. 2005a ; 31: 608-612 (Pubitemid 41253312)
55. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2005b ; 330: 11
56. Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM. Gene-environment interplay between cannabis and psychosis. Schizophr Bull. 2008 ; 34: 1111-1121
57. Henquet C, Rosa A, Delespaul P, Papiol S, Fananás L, van Os J, et al. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiatr Scand. 2009 ; 119: 156-160
58. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci. 1991 ; 11: 563-583
59. Higuera-Matas A, Soto-Montenegro ML, del Olmo N, Miguéns M, Torres I, Vaquero JJ, et al. Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology. 2008 ; 33: 806-813 (Pubitemid 351252702)
60. Higuera-Matas A, Botreau F, Miguéns M, Del Olmo N, Borcel E, Pérez-Alvarez L, et al. Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory. Pharmacol Biochem Behav. 2009 ; 93: 482-490
61. Higuera-Matas A, Botreau F, Del Olmo N, Miguéns M, Olías O, Montoya GL, et al. Periadolescent exposure to cannabinoids alters the striatal and hippocampal dopaminergic system in the adult rat brain. Eur Neuropsychopharmacol. 2010 ; 20: 895-906
62. Howlett AC. The cannabinoid receptors. Prostaglandins Other Lipid Mediat. 2002 ; 68-69: 619-631 (Pubitemid 35247425)
63. Katz LC, Shatz CJ. Synaptic activity and the construction of cortical circuits. Science. 1996 ; 274: 1133-1138 (Pubitemid 26389269)
64. Lane DA, Chan J, Lupica CR. Cannabinoid-1 receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of μ-opioid receptors and on dopamine axons in the mouse nucleus accumbens. Synapse. 2010 ; 64: 886-897
65. Le Bec PY, Fatséas M, Denis C, Lavie E, Auriacombe M. Cannabis and psychosis: search of a causal link through a critical and systematic review. Encephale. 2009 ; 35: 377-385
66. Lee KS, Clough AR, Jaragba MJ, Conigrave KM, Patton GC. Heavy cannabis use and depressive symptoms in three Aboriginal communities in Arnhem Land, Northern Territory. Med J Aust. 2008 ; 188: 605-608
67. Lessem JM, Hopfer CJ, Haberstick BC, Timberlake D, Ehringer MA, Smolen A, et al. Relationship between adolescent marijuana use and young adult illicit drug use. Behav Genet. 2006 ; 36: 498-506 (Pubitemid 43967646)
68. Leweke FM, Schneider M. Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine. Int J Neuropsychopharmacol. 2010 ; 3: 1-9
69. Long LE, Chesworth R, Arnold JC, Karl T. A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. Psychopharmacology (Berl). 2010 ; 211: 277-289
70. Luna B. Developmental changes in cognitive control through adolescence. Adv Child Dev Behav. 2009 ; 37: 233-278
71. Lynskey MT, Heath AC, Bucholz KK, Slutske WS, Madden PA, Nelson EC, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA. 2003 ; 289: 427-433 (Pubitemid 36119962)
72. Marcotte ER, Pearson DM, Srivastava LK. Animal models of schizophrenia: a critical review. J Psychiatry Neurosci. 2001 ; 26: 395-410 (Pubitemid 34082728)
73. Mateos B, Borcel E, Loriga R, Luesu W, Bini V, Llorente R, et al. Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB1 cannabinoid receptors. J Psychopharmacol. 2010 ; 25: 1676-1690
74. Matias I, Bisogno T, di Marzo V. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obes (Lond). 2006 ; 1: S7 - S12
75. Mato S, Del Olmo E, Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci. 2003 ; 17: 1747-1754 (Pubitemid 36645324)
76. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990 ; 346: 561-564
77. McGrath J, Welham J, Scott J, Varghese D, Degenhardt L, Hayatbakhsh MR, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010 ; 67: 440-447
78. McPartland JM, Glass M, Pertwee RG. Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br J Pharmacol. 2007 ; 152: 583-593 (Pubitemid 350034970)
79. Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol Teratol. 2007a ; 29: 141-152 (Pubitemid 46205161)
80. Medina KL, Hanson KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence. J Int Neuropsychol Soc. 2007b ; 13: 807-820 (Pubitemid 47299450)
81. Medina KL, Nagel BJ, Tapert SF. Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res. 2010 ; 30: 152-159
82. Monshouwer K, Smit F, de Graaf R, van Os J, Vollebergh W. First cannabis use: does onset shift to younger ages? Findings from 1988 to 2003 from the Dutch National School Survey on Substance Use. Addiction. 2005 ; 100: 963-970 (Pubitemid 40897291)
83. Morel LJ, Giros B, Daugé V. Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats. Neuropsychopharmacology. 2009 ; 34: 2469-2476
84. Morgan CJ, Schafer G, Freeman TP, Curran HV. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. Br J Psychiatry. 2010 ; 197: 285-290
85. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993 ; 365: 61-65 (Pubitemid 23305569)
86. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci. 2010 ; 13: 1161-1169
87. O'Shea M, Singh ME, McGregor IS, Mallet PE. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol. 2004 ; 18: 502-508 (Pubitemid 39665118)
88. O'Shea M, McGregor IS, Mallet PE. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. J Psychopharmacol. 2006 ; 20: 611-621 (Pubitemid 44315859)
89. O'Sullivan SE. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol. 2007 ; 152: 576-582 (Pubitemid 350034977)
90. O'Tuathaigh CM, Hryniewiecka M, Behan A, Tighe O, Coughlan C, Desbonnet L, et al. Chronic adolescent exposure to δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. Neuropsychopharmacology. 2010 ; 35: 2262-2273
91. Padula CB, Schweinsburg AD, Tapert SF. Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users. Psychol Addict Behav. 2007 ; 21: 478-487
92. Pardon MC, Gould GG, Garcia A, Phillips L, Cook MC, Miller SA, et al. Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders. Neuroscience. 2002 ; 115: 229-242 (Pubitemid 35232702)
93. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. BMJ. 2002 ; 325: 1195-1198 (Pubitemid 35398781)
94. Perry W, Minassian A, Feifel D, Braff DL. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry. 2001 ; 50: 418-424 (Pubitemid 32885591)
95. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 2003 ; 4: 873-884 (Pubitemid 37351427)
96. Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiatry. 2004 ; 56: 86-94 (Pubitemid 38849412)
97. Pope HG, Gruber AJ, Yurgelun-Todd D. Residual neuropsychologic effects of cannabis. Curr Psychiatry Rep. 2001 ; 3: 507-512
98. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Cognitive measures in long-term cannabis users. J Clin Pharmacol. 2002 ; 42: 41S - 47S (Pubitemid 35205045)
99. Pope HG, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association?. and. 2003 ; 69: 303-310 (Pubitemid 36293942)
100. Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, et al. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology. 2008 ; 33: 1113-1126 (Pubitemid 351367534)
101. Rapoport JL, Addington AM, Frangou S, Psych MRC. The neurodevelopmental model of schizophrenia. Mol Psychiatry. 2005 ; 10: 434-449
102. Realini N, Vigano D, Guidali C, Zamberletti E, Rubino T, Parolaro D. Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology. 2010 ; 60: 235-243
103. Rey JM, Sawyer MG, Raphael B, Patton GC, Lynskey M. Mental health of teenagers who use cannabis. Results of an Australian survey. Br J Psychiatry. 2002 ; 180: 216-221
104. Rodríguez-Arias M, Manzanedo C, Roger-Sánchez C, Do Couto BR, Aguilar MA, Miñarro J. Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference. Prog Neuropsychopharmacol Biol Psychiatry. 2010 ; 34: 166-171
105. Rodríguez de Fonseca F, Ramos JA, Bonnin A, Fernández-Ruiz JJ. Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport. 1993 ; 4: 135-138 (Pubitemid 23080859)
106. Ross RA. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol. 2003 ; 140: 790-801 (Pubitemid 37464060)
107. Rouzer CA, Marnett LJ. Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J Biol Chem. 2008 ; 283: 8065-8069
108. Rubino T, Vigano D, Realini N, Guidali C, Braida D, Capurro V, et al. Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology. 2008 ; 33: 2760-2771
109. Rubino T, Realini N, Braida D, Alberio T, Capurro V, Viganò D, et al. The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex. Neurotox Res. 2009a ; 15: 291-302
110. Rubino T, Realini N, Braida D, Guidi S, Capurro V, Viganò D, et al. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus. 2009b ; 19: 763-772
111. Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007 ; 152: 1092-1101 (Pubitemid 350166046)
112. Results from the 2006 National Survey on Drug Use and Health: National Findings. Rockville, MD: ; 2007 :
113. Schneider M, Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology. 2003 ; 28: 1760-1769 (Pubitemid 41070841)
114. Schneider M, Koch M. The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion. Eur Neuropsychopharmacol. 2007 ; 17: 180-186 (Pubitemid 44779191)
115. Schneider M, Drews E, Koch M. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2. Behav Pharmacol. 2005 ; 16: 447-454
116. Schweinsburg AD, Brown SA, Tapert SF. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev. 2008a ; 1: 99-111
117. Schweinsburg AD, Nagel BJ, Schweinsburg BC, Park A, Theilmann RJ, Tapert SF. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res. 2008b ; 163: 40-51
118. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol. 2005 ; 19: 187-194 (Pubitemid 40577224)
119. Solowij N, Pesa N. Cognitive abnormalities and cannabis use. Rev Bras Psiquiatr. 2010 ; 32: 31-40
120. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA. 2002 ; 287: 1123-1131 (Pubitemid 34252081)
121. Spear L. Modeling adolescent development and alcohol use in animals. Alcohol Res Health. 2000 ; 24: 115-123
122. Steinberg L, Morris AS. Adolescent development. Annu Rev Psychol. 2001 ; 52: 83-110 (Pubitemid 33705568)
123. Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 1997 ; 388: 773-778 (Pubitemid 27375156)
124. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 1995 ; 215: 89-97
125. Sugranyes G, Flamarique I, Parellada E, Baeza I, Goti J, Fernandez-Egea E, et al. Cannabis use and age of diagnosis of schizophrenia. Eur Psychiatry. 2009 ; 24: 282-286
126. Tõnissaar M, Herm L, Eller M, Kõiv K, Rinken A, Harro J. Rats with high or low sociability are differently affected by chronic variable stress. Neuroscience. 2008 ; 152: 867-876
127. UNODC (United Nations Office on Drug and Crime) (2007) UNODC World Drug Report. Retrieved from http://www.unodc.org/unodc/en/data-and-analysis/WDR-2007. html (accessed January 2011).
128. Uriguen L, García-Gutiérrez MS, Manzanares J. Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice. J Psychopharmacol. 2011 ; 25: 105-110
129. Van den Buuse M. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull. 2010 ; 36: 246-270
130. Van Laar M, van Dorsselaer S, Monshouwer K, de Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?. Addiction. 2007 ; 102: 1251-1260 (Pubitemid 47037929)
131. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005 ; 310: 329-332 (Pubitemid 41457202)
132. Vigano D, Guidali C, Petrosino S, Realini N, Rubino T, Di Marzo V, et al. Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. Int J Neuropsychopharmacol. 2009 ; 12: 599-614
133. Wagner FA, Anthony JC. Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am J Epidemiol. 2002 ; 15: 918-925 (Pubitemid 34517848)
134. Wegener N, Koch M. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment. Brain Res. 2009 ; 1253: 81-91
135. Wenger T, Gerendai I, Fezza F, González S, Bisogno T, Fernandez-Ruiz J, et al. The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats. Life Sci. 2002 ; 70: 1407-1414 (Pubitemid 34159097)
136. Whitford TJ, Rennie CJ, Grieve SM, Clark CR, Gordon E, Williams LM. Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology. Hum Brain Mapp. 2007 ; 28: 228-237 (Pubitemid 46340078)
137. Wilcox HC, Anthony JC. The development of suicide ideation and attempts: an epidemiologic study of first graders followed into young adulthood. Drug Alcohol Depend. 2004 ; 7: S53 - S67
138. Yücel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008 ; 65: 694-701 (Pubitemid 351787240)